18 May 2009 - Argenta Discovery and Porsolt have entered into an alliance to provide CNS and pain drug discovery services and expertise on a fee-for-service basis.
The collaboration enables Argenta and Porsolt to undertake fully integrated CNS and pain-focused drug discovery programmes for clients, from hit identification to development candidate nomination.
